The oral immunogenicity of BioProtein, a bacterial single-cell protein, is affected by its particulate nature

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

The oral immunogenicity of BioProtein, a bacterial single-cell protein, is affected by its particulate nature. / Christensen, Hanne R.; Larsen, Linea C.; Frøkiær, Hanne.

In: British Journal of Nutrition, Vol. 90, No. 1, 01.07.2003, p. 169-178.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Christensen, HR, Larsen, LC & Frøkiær, H 2003, 'The oral immunogenicity of BioProtein, a bacterial single-cell protein, is affected by its particulate nature', British Journal of Nutrition, vol. 90, no. 1, pp. 169-178. https://doi.org/10.1079/BJN2003863

APA

Christensen, H. R., Larsen, L. C., & Frøkiær, H. (2003). The oral immunogenicity of BioProtein, a bacterial single-cell protein, is affected by its particulate nature. British Journal of Nutrition, 90(1), 169-178. https://doi.org/10.1079/BJN2003863

Vancouver

Christensen HR, Larsen LC, Frøkiær H. The oral immunogenicity of BioProtein, a bacterial single-cell protein, is affected by its particulate nature. British Journal of Nutrition. 2003 Jul 1;90(1):169-178. https://doi.org/10.1079/BJN2003863

Author

Christensen, Hanne R. ; Larsen, Linea C. ; Frøkiær, Hanne. / The oral immunogenicity of BioProtein, a bacterial single-cell protein, is affected by its particulate nature. In: British Journal of Nutrition. 2003 ; Vol. 90, No. 1. pp. 169-178.

Bibtex

@article{1991483080de4f2dbbbcfcf11e1f890d,
title = "The oral immunogenicity of BioProtein, a bacterial single-cell protein, is affected by its particulate nature",
abstract = "The bacterial single-cell protein BioProtein (BP; Norferm Danmark, Odense, Denmark), produced by fermentation of natural gas with methanotrophic bacteria, is a potential protein source for man and animals. For human consumption, removal of the nucleic acid is necessary. Preliminary studies have shown that ingested BP induces a specific immune response. The objective of the present study was to characterize the type of response, its development over time and product-related causative factors. Mice were fed with diets containing 60 g nucleic acid-reduced BP/kg, 240 g nucleic acid-reduced BP/kg, 240 g untreated BP (basic BP)/kg or 240 g casein/kg (control). In another study, mice were fed 240 g basic BP/kg, whole cell-free BP-culture homogenate or control diet. The immune response was monitored using an ELISA for BP-specific immunoglobulin in blood and BP-specific immunoglobulin A in blood and saliva. Ingested BP induced a steady specific mucosal and systemic immune response, characterized by a dose-dependent production of immunoglobulin and immunoglobulin A in blood and immunoglobulin A in saliva. Basic BP and nucleic acid-reduced BP induced identical responses. However, feeding mice BP-culture homogenate induced immunoglobulin A in saliva but there was no systemic response. The antibodies from BP-fed mice cross-reacted with BP-culture homogenate revealing the presence of the same antigenic components in the two products despite the different oral immunogenicity. Thus, ingestion of BP induces a persistent mucosal and systemic immune response of which the systemic response can be avoided by ingesting a BP preparation free of whole cells. This indicates the importance of the non-particulate constitution of single-cell protein products intended for human or animal consumption.",
keywords = "BioProtein, Oral immunogenicity, Particulate food antigen, Single-cell protein",
author = "Christensen, {Hanne R.} and Larsen, {Linea C.} and Hanne Fr{\o}ki{\ae}r",
year = "2003",
month = jul,
day = "1",
doi = "10.1079/BJN2003863",
language = "English",
volume = "90",
pages = "169--178",
journal = "British Journal of Nutrition",
issn = "0007-1145",
publisher = "Cambridge University Press",
number = "1",

}

RIS

TY - JOUR

T1 - The oral immunogenicity of BioProtein, a bacterial single-cell protein, is affected by its particulate nature

AU - Christensen, Hanne R.

AU - Larsen, Linea C.

AU - Frøkiær, Hanne

PY - 2003/7/1

Y1 - 2003/7/1

N2 - The bacterial single-cell protein BioProtein (BP; Norferm Danmark, Odense, Denmark), produced by fermentation of natural gas with methanotrophic bacteria, is a potential protein source for man and animals. For human consumption, removal of the nucleic acid is necessary. Preliminary studies have shown that ingested BP induces a specific immune response. The objective of the present study was to characterize the type of response, its development over time and product-related causative factors. Mice were fed with diets containing 60 g nucleic acid-reduced BP/kg, 240 g nucleic acid-reduced BP/kg, 240 g untreated BP (basic BP)/kg or 240 g casein/kg (control). In another study, mice were fed 240 g basic BP/kg, whole cell-free BP-culture homogenate or control diet. The immune response was monitored using an ELISA for BP-specific immunoglobulin in blood and BP-specific immunoglobulin A in blood and saliva. Ingested BP induced a steady specific mucosal and systemic immune response, characterized by a dose-dependent production of immunoglobulin and immunoglobulin A in blood and immunoglobulin A in saliva. Basic BP and nucleic acid-reduced BP induced identical responses. However, feeding mice BP-culture homogenate induced immunoglobulin A in saliva but there was no systemic response. The antibodies from BP-fed mice cross-reacted with BP-culture homogenate revealing the presence of the same antigenic components in the two products despite the different oral immunogenicity. Thus, ingestion of BP induces a persistent mucosal and systemic immune response of which the systemic response can be avoided by ingesting a BP preparation free of whole cells. This indicates the importance of the non-particulate constitution of single-cell protein products intended for human or animal consumption.

AB - The bacterial single-cell protein BioProtein (BP; Norferm Danmark, Odense, Denmark), produced by fermentation of natural gas with methanotrophic bacteria, is a potential protein source for man and animals. For human consumption, removal of the nucleic acid is necessary. Preliminary studies have shown that ingested BP induces a specific immune response. The objective of the present study was to characterize the type of response, its development over time and product-related causative factors. Mice were fed with diets containing 60 g nucleic acid-reduced BP/kg, 240 g nucleic acid-reduced BP/kg, 240 g untreated BP (basic BP)/kg or 240 g casein/kg (control). In another study, mice were fed 240 g basic BP/kg, whole cell-free BP-culture homogenate or control diet. The immune response was monitored using an ELISA for BP-specific immunoglobulin in blood and BP-specific immunoglobulin A in blood and saliva. Ingested BP induced a steady specific mucosal and systemic immune response, characterized by a dose-dependent production of immunoglobulin and immunoglobulin A in blood and immunoglobulin A in saliva. Basic BP and nucleic acid-reduced BP induced identical responses. However, feeding mice BP-culture homogenate induced immunoglobulin A in saliva but there was no systemic response. The antibodies from BP-fed mice cross-reacted with BP-culture homogenate revealing the presence of the same antigenic components in the two products despite the different oral immunogenicity. Thus, ingestion of BP induces a persistent mucosal and systemic immune response of which the systemic response can be avoided by ingesting a BP preparation free of whole cells. This indicates the importance of the non-particulate constitution of single-cell protein products intended for human or animal consumption.

KW - BioProtein

KW - Oral immunogenicity

KW - Particulate food antigen

KW - Single-cell protein

UR - http://www.scopus.com/inward/record.url?scp=0042871291&partnerID=8YFLogxK

U2 - 10.1079/BJN2003863

DO - 10.1079/BJN2003863

M3 - Journal article

C2 - 12844389

AN - SCOPUS:0042871291

VL - 90

SP - 169

EP - 178

JO - British Journal of Nutrition

JF - British Journal of Nutrition

SN - 0007-1145

IS - 1

ER -

ID: 316999323